Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 36, 2007 - Issue 2
65
Views
2
CrossRef citations to date
0
Altmetric
Original

Effect of AC II, an Herbal Formulation in Cyclophosphamide-Induced Immunosuppression in BALB/c Mice—Implication in HIV Treatment

, , , , &
Pages 147-157 | Published online: 07 Jul 2009

REFERENCES

  • Agarwal R., Diwanay S., Patki P., Patwardhan B. Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J. Ethnopharmacol 1999; 67(1)27–35
  • Bancroft J. D., Cook H. C. Manual of Histologic Techniques. Churchill Living Stone, London 1984; 171–178
  • Berger N. A. Alkylating agents. Cancer Principles and Practice of Oncology, V.T. DeVita, S. Hellman, S.A. Rosenberg. J.B. Lippincott Company, Philadelphia 1993; 403–409
  • Colvin O. M. Alkylating agents and platinum antitumour compounds. Cancer Medicine, J. F. Holland, E. Frie, R. C. Bast, D. N. Kufe, D. L. Morton, R. R. Weichselbaum. Williams and Wilkins, Baltimore 1997; 949–951
  • Colvin O. M. Antitumor alkylating agents. Cancer Principles and Practice of Oncology, V. T. DeVita, S. Hellman, S. A. Rosenberg. Lippincott Williams and Wilkins, Philadelphia 2001; 363–376
  • Davis L., Kuttan G. Suppressive effect of cyclophosphamide – induced toxicity by Withania somnifera in mice. J. Ethnopharmacol 1998; 62(3)209–214
  • Davis L., Kuttan G. Immunomodulatory activity of Withania somnifera. J. Ethnopharmcol 1999; 71: 193–200
  • Davis L., Kuttan G. Effect of Withania somnifera on cyclophosphamide- induced urotoxicity. Cancer Lett 2000; 148(1)9–17
  • Devasagayam T. P. A., Sainis K.B. Immune system and antioxidants, especially those derived from Indian medicinal plants. Ind. J. Exp. Biol 2002; 40: 639–655
  • Diwanay S., Chitre D., Patwardhan B. Immunoprotection by botanical drugs in cancer chemotherapy. J. Ethnopharmacol 2004; 90(1)49–55
  • Drabkin D. L., Austin J. M. Spectrophotometric studies, spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J. Biol. Chem. 1932; 98: 719–733
  • Growchow L. B. Covalent DNA-binding drugs. The Chemotherapy Source Book, M. C. Perry. Williams and Wilkins, Baltimore 1996; 297–299
  • Jones S. E., Durie B. J. M., Salman S. E. Combination therapy with Adriamycin and cyclophosphamide for advanced breast carcinoma. Cancer 1975; 36: 90–97
  • Kesavan M., Rajagopalan K., Kuttan G., Kuttan R. Clinical evaluation for the efficacy of an Ayurvedic drug formulation against HIV and AIDS. Amala Res. Bull 1998; 18: 117–122
  • Kesavan M., Austin Sr., Rajagopalan K., Kuttan R. The efficacy of Ayurvedic drug formulations against HIV/AIDS disease. Proceedings of the National Seminar on the Use of Traditional Medicines in HIV Infection and AIDS. Sept, 21–22, 2002; 9–19
  • Krishna G., Nath J., Ong T. Inhibition of cyclophosphamide and mitomycin c-induced sister chromatid exchanges in mice by vitamin C. Cancer Res 1986; 46: 2670–2674
  • Kuttan G., Kuttan R. Reduction of leucopenia in mice by Viscum album administration during radiation and chemotherapy. Tumori 1993; 70: 74–76
  • Praveen K., Kuttan R., Kuttan G. Radioprotective effect of Rasayanas. Ind. J. Expt. Biol 1996; 34: 848–850
  • Praveen K. V., Kuttan G., Kuttan R. Protective effect of Rasayanas on cyclophosphamide- and radiation-induced damage. J. Altern. Compl. Med 2002; 8: 787–796
  • Sredni B., Albeck M., Kazimmirsky G., Shalit F. The immunomodulator administered orally as a radioprotective agent. Int. J. Immunopharmacol 1992; 14: 619
  • Salvin R. E., Millan J. C., Mullins G. M. Pathology of high dose intermittent cyclophosphamide therapy. Hum. Pathol 1975; 6: 693–699
  • Tharakan T. S., Kesavan M., Kuttan G., Kuttan R. Immunomodulatory and toxicity study of NCV I and AC II - drugs useful against human immunodeficiency virus. Amala Res. Bull. 2003; 23: 64–71

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.